- Ironwood Pharmaceuticals (NASDAQ:IRWD) is scheduled to announce Q4 earnings results on Thursday, February 15th, before market open.
- The consensus EPS Estimate is $0.16 (-40.7% Y/Y) and the consensus Revenue Estimate is $117.4M (+9.5% Y/Y).
- Over the last 2 years, IRWD has beaten EPS estimates 50% of the time and has beaten revenue estimates 63% of the time.
More on Ironwood Pharmaceuticals
- Ironwood Pharmaceuticals: Capitalizing On GI Healthcare's Growing Potential
- Ironwood Pharmaceuticals expects 2024 revenue to be below consensus
- Seeking Alpha’s Quant Rating on Ironwood Pharmaceuticals
- Historical earnings data for Ironwood Pharmaceuticals
- Financial information for Ironwood Pharmaceuticals